Clinical Trials in Chicago

Showing 3661-3680 of 9,860 trials

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

NCT02052648

In this study, investigators will conduct a phase I/II trial in recurrent (temozolomide resistant) glioma patients. The overall goal of this study is to provide a foundation for future studies with indoximod tested in newly diagnosed glioblastoma patients with radiation and temozolomide, or in combination with vaccine therapies.

Glioblastoma MultiformeGliomaGliosarcoma+1 more

NewLink Genetics Corporation160 participantsStarted Mar 2014

Castro Valley, California, United States • Los Angeles, California, United States • Orange, California, United States +14 more locations

COMPLETEDPhase 22.2 miles

Evaluation of S-600918 in Adults With Refractory Chronic Cough

NCT04110054

The primary objective of this study is to determine the optimal dose of S-600918 in patients with refractory chronic cough by evaluating the change from baseline in 24-hour cough frequency (coughs per hour) with S-600918 compared with placebo.

Chronic Cough

Shionogi406 participantsStarted Feb 2020

Litchfield Park, Arizona, United States • Phoenix, Arizona, United States • Tempe, Arizona, United States +133 more locations

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

Evaluation of S-600918 in Adults With Refractory Chronic Cough

Find Trials by Condition in Chicago

Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Pediatric EEG Monitoring

Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

Thermal Pulsation Versus Warm Compress Treatment for Meibomian Gland Dysfunction

A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

PRESERFLO® MicroShunt Extension Study

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT

CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma

Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort

A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)

Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults

A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in Healthy Volunteers

A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders